Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Xortx Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.75
06.03.24
-
06.03.25
-3.37%
16.03.24

Probably not worthwhile Investment
buy
Albemarle Corp

Start price
Target price
Perf. (%)
€102.40
05.03.24
-
05.03.25
16.45%
03.04.24

Growths faster than the competition
buy
NIO Inc.

Start price
Target price
Perf. (%)
€5.05
05.03.24
€6.00
02.03.25
-0.67%
07.03.24

Known brand
Ocean Biomedical Inc.

Start price
Target price
Perf. (%)
€6.65
05.03.24
-
05.03.25
-44.36%
16.03.24

Probably not worthwhile Investment
buy
BYD Co. Ltd

Start price
Target price
Perf. (%)
€22.46
05.03.24
€23.00
05.03.25
8.37%
12.03.24

Risky Investment
High valuation
Low dividend yield expected
negative Cash Flow expected
NIO Inc.

Start price
Target price
Perf. (%)
€4.98
05.03.24
€6.00
02.03.25
1.39%
05.03.24

Known brand
buy
Netflix Inc.

Start price
Target price
Perf. (%)
€565.10
05.03.24
€570.00
05.03.25
4.58%
12.04.24

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
buy
Barrick Gold Corp

Start price
Target price
Perf. (%)
€14.38
05.03.24
€15.00
05.03.25
4.28%
28.03.24

Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Spineway

Start price
Target price
Perf. (%)
€4.49
05.03.24
-
05.03.25
-57.91%
16.03.24

Good culture
Risky Investment
No uniques
Deficits in Management
NIO Inc.

Start price
Target price
Perf. (%)
€4.97
04.03.24
-
04.03.25
-15.79%
04.04.24

Ocean Biomedical Inc.

Start price
Target price
Perf. (%)
€3.92
04.03.24
-
04.03.25
-5.61%
16.03.24

Innovative
No uniques
Probably not worthwhile Investment
buy
Helma Eigenheimbau AG

Start price
Target price
Perf. (%)
€0.66
04.03.24
-
04.03.25
-59.55%
16.03.24

Could be worthwhile Investment >10% per year
Good culture
Below average Management
buy
Msp Recovery Inc.

Start price
Target price
Perf. (%)
€1.13
04.03.24
-
04.03.25
-33.19%
16.03.24

Capable Management
Could be worthwhile Investment >10% per year
Good culture
Few uniques
Super Micro Computer

Start price
Target price
Perf. (%)
€1,044.5
04.03.24
-
04.03.25
-3.73%
16.03.24

Capable Management
Probably not worthwhile Investment
Few uniques
buy
Sixt SE ST

Start price
Target price
Perf. (%)
€89.80
04.03.24
€91.00
04.03.25
4.40%
18.04.24

EBIT growth >5% per year expected
Top Rating
Very valuable balance sheet
Normal challenges to pay loans and raise capital
buy
Barrick Gold Corp

Start price
Target price
Perf. (%)
€13.86
04.03.24
€14.00
04.03.25
3.75%
05.03.24

Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
buy
Minim Inc.

Start price
Target price
Perf. (%)
€4.50
04.03.24
€11.00
04.03.25
22.22%
18.03.24

Could be very worthwhile Investment >20% year
buy
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€3.74
04.03.24
-
04.03.25
-24.06%
17.03.24

Could be very worthwhile Investment >20% year
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€25.60
04.03.24
-
04.03.25
-0.78%
15.03.24

Risky Investment
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€4.00
04.03.24
-
04.03.25
-13.00%
16.03.24

Probably not worthwhile Investment
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€8.50
03.03.24
-
03.03.25
0.12%
15.03.24

Risky Investment
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.96
03.03.24
-
03.03.25
10.06%
15.03.24

Could be very worthwhile Investment >20% year
buy
Hyundai Motor Co. Ltd.

Start price
Target price
Perf. (%)
€89.00
03.03.24
€128.00
-
15.03.24

Apple Inc.

Start price
Target price
Perf. (%)
€164.60
02.03.24
-
02.03.25
-2.65%
28.03.24

buy
Peloton Interactive Inc.

Start price
Target price
Perf. (%)
€4.23
02.03.24
€5.00
02.03.25
4.98%
11.03.24

Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
Very positive Cash Flow expected